The Effects of Self-monitoring With a Mobile Application in Heart Failure
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 45 - Any |
| Updated: | 5/25/2018 |
| Start Date: | March 6, 2017 |
| End Date: | April 30, 2019 |
| Contact: | Judith Grossi |
| Email: | jgrossi@med.umich.edu |
| Phone: | 734-232-6367 |
A Patient-centered Mobile Intervention to Promote Self-management and Improve Patient Outcomes in Chronic Heart Failure
In the United States, about 40 percent of heart failure (HF) patients are readmitted within
1-year following their first admission for HF and hospitalization accounts for approximately
70 percent of the costs of HF management. As a result, the management of HF patients is
evolving from the traditional model of face-to-face follow-up visits toward a proactive
real-time technological model of assisting patients with monitoring and self-management while
in the community. The investigators plan to test the impact of a mobile application on
clinical outcomes in HF.
1-year following their first admission for HF and hospitalization accounts for approximately
70 percent of the costs of HF management. As a result, the management of HF patients is
evolving from the traditional model of face-to-face follow-up visits toward a proactive
real-time technological model of assisting patients with monitoring and self-management while
in the community. The investigators plan to test the impact of a mobile application on
clinical outcomes in HF.
HF patients with a reduced ejection fraction will be randomized to the mobile application
versus placebo for 12 weeks. The mobile application will provide the participants with a
reminder to perform self-monitoring, a health status indicator and heart failure education
for self-management.
All participants will complete the Minnesota Living with Heart Failure Questionnaire and
Self-Care Heart Failure Index. Hospital admissions and mortality will also be collected.
versus placebo for 12 weeks. The mobile application will provide the participants with a
reminder to perform self-monitoring, a health status indicator and heart failure education
for self-management.
All participants will complete the Minnesota Living with Heart Failure Questionnaire and
Self-Care Heart Failure Index. Hospital admissions and mortality will also be collected.
Inclusion Criteria:
- 45 years old or older
- Left ventricular ejection fraction 40% (with left atrial size
>40mm or BNP > 200 pg/ml or NT-proBNP > 800 pg/ml)
- Admitted for acutely decompensated heart failure or recently discharged in the past 4
weeks.
- Smartphone (iOS or Android) with home wifi
Exclusion Criteria:
- Unstable coronary syndrome within 8 weeks (unstable angina, NSTEMI, STEMI)
- Primary valvular heart disease
- Known pericardial disease (Sarcoidosis, amyloidosis, rheumatoid arthritis, lupus)
- Uncorrected thyroid disease
- Advanced renal disease (dialysis or creatinine >4.0 mg/dL)
- End-stage HF (hospice candidate, home milrinone or dobutamine)
- Active cancer
- Pulmonary fibrosis
- Discharge to a setting other than home
We found this trial at
2
sites
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health System The University of Michigan is home to one of the...
Click here to add this to my saved trials
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials